1. 3334 Durable complete responses (CR) in patients (pts) with stage IIIB-IV melanoma treated with talimogene laherparepvec (T-VEC) in OPTiM. (September 2015) Authors: Andtbacka, R.H.I.; Kaufman, H.; Collichio, F.; Amatruda, T.; Nemunaitis, J.; Chesney, J.; Puzanov, I.; Harrington, K.; Zhang, Y.; Chen, L.; Shilkrut, M.; Ross, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S676 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0513: Radiation necrosis following stereotactic RT and immunotherapy for melanoma brain metastases. (May 2017) Authors: Kaidar-Person, O.; Zagar, T.; Deal, A.; Moschos, S.; Ewend, M.; Sasaki-Adams, D.; Lee, C.; Collichio, F.; Fried, D.; Marks, L.; Chera, B. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗